Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Explore what a balanced crypto portfolio looks like to understand successful investment strategies. Visualize your future gains.
25,379 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
These software stocks have surged as geopolitical tensions rise, outpacing broader tech gains and signaling a shift i...
QVC is leaning into TikTok's live shopping fever as traditional TV fades. The move aims to spark a new growth engine ...
Lam Research shares jump on stronger AI-related demand for semiconductor equipment. With foundries expanding capacity...
P3 Health's Q1 2026 results set the stage for an important year in health services. This analysis breaks down the ear...
Ford stock surged 8% on Friday, easily outpacing General Motors and Stellantis as investors focus on Ford Energy and ...
Companies are ditching token-based performance dashboards as ROI from AI pivots to concrete business outcomes like re...
A mounting deficit of $3.4 trillion is shaping long-term borrowing costs, with the 30-year fixed mortgage lingering n...
The latest weekly data shows a spike in initial claims, but the broader labor market remains resilient. Analysts warn...
A long-remembered jab about Chrome’s prospects resurfaces as the browser landscape continues to evolve. Here’s what i...
Nvidia announces a breakthrough that isn’t a chip, signaling a new era for AI infrastructure. Investors react as data...
Medicare’s IRMAA line can surprise retirees: income jumps today may raise premiums two years later. Experts outline h...